• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 型利钠肽和 N 端 B 型利钠肽原在儿科患者中的临床意义:预先存在的心脏疾病对其应用价值的影响。

Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions.

机构信息

Department of Pediatric Infectious Diseases, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, Poland.

Department of Physiology and Pathophysiology, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, Poland.

出版信息

Int J Mol Sci. 2024 Aug 12;25(16):8781. doi: 10.3390/ijms25168781.

DOI:10.3390/ijms25168781
PMID:39201467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11354905/
Abstract

The clinical significance of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in pediatric patients remains an area of evolving understanding, particularly regarding their utility in the presence or absence of pre-existing heart conditions. While clear cutoff values and established roles in heart failure are understood in adult patients, pediatric norms vary with age, complicating interpretation. Notably, the emergence of multi-system inflammatory syndrome in children (MIS-C) has highlighted the importance of these markers not only in the detection of acute heart failure but also as a marker of disease severity and even as a differential diagnosis tool. This review summarizes current knowledge on the utility of BNP and NT-proBNP in pediatric patients. Their unique physiology, including circulation and compensation mechanisms, likely influence BNP and NT-proBNP release, potentially even in non-heart failure states. Factors such as dynamic volemic changes accompanying inflammatory diseases in children may contribute. Thus, understanding the nuanced roles of BNP and NT-proBNP in pediatric populations is crucial for the accurate diagnosis, management, and differentiation of cardiac and non-cardiac conditions.

摘要

B 型利钠肽(BNP)和 N 端脑利钠肽前体(NT-proBNP)在儿科患者中的临床意义仍在不断深入研究,特别是在存在或不存在预先存在的心脏疾病的情况下,其应用价值。虽然在成年患者中,BNP 和 NT-proBNP 在心力衰竭中的明确截断值和既定作用已得到理解,但儿科的正常范围随年龄而变化,这使得解释变得复杂。值得注意的是,儿童多系统炎症综合征(MIS-C)的出现突显了这些标志物的重要性,不仅在于急性心力衰竭的检测,还在于疾病严重程度的标志物,甚至作为鉴别诊断工具。本综述总结了 BNP 和 NT-proBNP 在儿科患者中的应用价值。它们独特的生理学,包括循环和代偿机制,可能会影响 BNP 和 NT-proBNP 的释放,甚至在非心力衰竭状态下也是如此。儿童炎症性疾病伴随的动态血容量变化等因素可能会起作用。因此,了解 BNP 和 NT-proBNP 在儿科人群中的细微作用对于准确诊断、管理和区分心脏和非心脏疾病至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb63/11354905/9a8546e4d660/ijms-25-08781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb63/11354905/9a8546e4d660/ijms-25-08781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb63/11354905/9a8546e4d660/ijms-25-08781-g001.jpg

相似文献

1
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions.B 型利钠肽和 N 端 B 型利钠肽原在儿科患者中的临床意义:预先存在的心脏疾病对其应用价值的影响。
Int J Mol Sci. 2024 Aug 12;25(16):8781. doi: 10.3390/ijms25168781.
2
Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.B 型利钠肽和氨基末端 B 型利钠肽前体在单心室先天性心脏病幼儿心力衰竭中的标志物作用。
Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.
3
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.心血管危险因素稳定门诊患者中N末端B型利钠肽原/ B型利钠肽的摩尔比与心力衰竭相关事件的关系
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
4
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.B 型利钠肽与氨基末端 pro-B 型利钠肽:在肾功能受损患者中选择最佳心力衰竭标志物。
BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.
5
The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.血浆脑钠肽检测在先天性心脏病所致儿童心力衰竭诊断、预后评估及管理中的潜力与局限性:最新进展
Heart Fail Rev. 2014 Nov;19(6):727-42. doi: 10.1007/s10741-014-9422-2.
6
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.联合应用氨基末端 pro-B 型利钠肽原和 B 型利钠肽对心力衰竭住院患者预后的评估。
Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28.
7
The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.N 端脑利钠肽前体在儿童充血性心力衰竭诊断中的作用。- 与心力衰竭评分的相关性及与 B 型利钠肽的比较。-
Circ J. 2010 May;74(5):998-1005. doi: 10.1253/circj.cj-09-0535. Epub 2010 Apr 6.
8
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.B型利钠肽和N末端B型利钠肽原作为近期发生冠状动脉事件的2型糖尿病患者心血管疾病发病率和死亡率预测指标的作用
J Am Heart Assoc. 2017 May 29;6(6):e004743. doi: 10.1161/JAHA.116.004743.
9
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭和射血分数降低患者中 BNP 和 NT-proBNP 的比较。
Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17.
10
High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.稳定型慢性心力衰竭患者B型利钠肽(BNP)和氨基末端前脑钠肽原(proBNP)的个体内高变异性。
Clin Chem. 2004 Nov;50(11):2052-8. doi: 10.1373/clinchem.2004.038752. Epub 2004 Sep 2.

引用本文的文献

1
Longitudinal Myocardial Deformation as an Emerging Biomarker for Post-Traumatic Cardiac Dysfunction.纵向心肌变形作为创伤后心脏功能障碍的一种新兴生物标志物。
Life (Basel). 2025 Jun 30;15(7):1052. doi: 10.3390/life15071052.
2
Diagnostic Efficacy of Combined N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) Testing in Myocardial Injury of Children with Pneumoniae Pneumonia.联合检测N末端脑钠肽前体(NT-proBNP)和心肌肌钙蛋白I(cTnI)对肺炎患儿心肌损伤的诊断效能
J Multidiscip Healthc. 2025 Jun 26;18:3709-3716. doi: 10.2147/JMDH.S527700. eCollection 2025.
3
Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center Experience.

本文引用的文献

1
NT-proBNP course during MIS-C post-COVID-19: an observational study.COVID-19 后患 MIS-C 期间 NT-proBNP 变化过程:一项观察性研究。
Eur J Pediatr. 2024 Apr;183(4):1667-1674. doi: 10.1007/s00431-023-05353-x. Epub 2024 Jan 11.
2
Elevated High-Sensitivity Troponin and NT-proBNP Values in Febrile Children.发热儿童中高敏肌钙蛋白和 N 末端脑利钠肽前体值升高。
Pediatr Emerg Care. 2024 Feb 1;40(2):108-113. doi: 10.1097/PEC.0000000000003097. Epub 2023 Dec 20.
3
Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
罗马尼亚川崎病患儿的当代诊断、管理及早期结局:单中心经验
Diagnostics (Basel). 2025 Mar 7;15(6):656. doi: 10.3390/diagnostics15060656.
4
Cardiac Markers in Pediatric Laboratory Medicine: Critical Review.儿科检验医学中的心脏标志物:批判性综述
Diagnostics (Basel). 2025 Jan 13;15(2):165. doi: 10.3390/diagnostics15020165.
PCT、BNP 及炎症因子在川崎病患儿中的表达及其与冠状动脉病变的相关性。
Altern Ther Health Med. 2024 Jan;30(1):302-306.
4
N-Terminal Pro-Brain Natriuretic Peptide Levels in Kawasaki Disease, Sepsis and Other Febrile Illnesses.川崎病、脓毒症和其他发热性疾病中的 N 端脑利钠肽前体水平。
Indian Pediatr. 2023 Oct 15;60(10):826-828. Epub 2023 Jun 21.
5
Brain natriuretic peptide as a clinical screening tool for the diagnosis of Kawasaki disease.脑利钠肽作为川崎病临床筛查工具的研究进展。
Medicine (Baltimore). 2023 Jul 21;102(29):e34319. doi: 10.1097/MD.0000000000034319.
6
Systematic review and meta-analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection.与 SARS-CoV-2 感染相关的多系统炎症综合征 (MIS-C) 的血清学、免疫学和心脏参数的系统评价和荟萃分析。
J Med Virol. 2023 Jul;95(7):e28927. doi: 10.1002/jmv.28927.
7
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry.COVID-19 与 MIS-C 时期的川崎病:国际川崎病注册研究。
Can J Cardiol. 2024 Jan;40(1):58-72. doi: 10.1016/j.cjca.2023.06.001. Epub 2023 Jun 7.
8
Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland.波兰儿童多系统炎症综合征(MIS-C)患者的心脏受累情况。
Biomedicines. 2023 Apr 23;11(5):1251. doi: 10.3390/biomedicines11051251.
9
Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection.COVID-19 感染后 MIS-C 中诊断时间对心源性休克发生的影响。
World J Pediatr. 2023 Jun;19(6):595-604. doi: 10.1007/s12519-022-00681-8. Epub 2023 Jan 6.
10
Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.川崎病临床特征及相关影响因素的回顾性分析。
Medicine (Baltimore). 2022 Dec 30;101(52):e32430. doi: 10.1097/MD.0000000000032430.